159 related articles for article (PubMed ID: 37798683)
21. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease.
Ohman L; Dahlén R; Isaksson S; Sjöling A; Wick MJ; Sjövall H; Van Oudenhove L; Simrén M; Strid H
Inflamm Bowel Dis; 2013 Oct; 19(11):2433-9. PubMed ID: 23966065
[TBL] [Abstract][Full Text] [Related]
22. Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease.
Nielsen OH; Rüdiger N; Gaustadnes M; Horn T
Scand J Gastroenterol; 1997 Oct; 32(10):1028-34. PubMed ID: 9361176
[TBL] [Abstract][Full Text] [Related]
23. The regulatory role of Nrf2 in antioxidants phase2 enzymes and IL-17A expression in patients with ulcerative colitis.
Sabzevary-Ghahfarokhi M; Shohan M; Shirzad H; Rahimian G; Soltani A; Ghatreh-Samani M; Deris F; Bagheri N; Shafigh M; Tahmasbi K
Pathol Res Pract; 2018 Aug; 214(8):1149-1155. PubMed ID: 29941222
[TBL] [Abstract][Full Text] [Related]
24. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
25. Influence of receptor activator of nuclear factor kappa B ligand, osteoprotegerin and interleukin-33 on bone metabolism in patients with long-standing ulcerative colitis.
Stanisławowski M; Wiśniewski P; Guzek M; Wierzbicki PM; Adrych K; Smoczyński M; Sworczak K; Celiński K; Kmieć Z
J Crohns Colitis; 2014 Aug; 8(8):802-10. PubMed ID: 24439762
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of inflammatory cytokines in intestinal mucosa and their prognostic value in patients with ulcerative colitis].
Lin AN; Li YQ; Zhong MX; Liu J; Dai Q; Zhu W; Zhang YL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Dec; 36(12):1712-1717. PubMed ID: 27998870
[TBL] [Abstract][Full Text] [Related]
27. Mucosal Expression of Type 2 and Type 17 Immune Response Genes Distinguishes Ulcerative Colitis From Colon-Only Crohn's Disease in Treatment-Naive Pediatric Patients.
Rosen MJ; Karns R; Vallance JE; Bezold R; Waddell A; Collins MH; Haberman Y; Minar P; Baldassano RN; Hyams JS; Baker SS; Kellermayer R; Noe JD; Griffiths AM; Rosh JR; Crandall WV; Heyman MB; Mack DR; Kappelman MD; Markowitz J; Moulton DE; Leleiko NS; Walters TD; Kugathasan S; Wilson KT; Hogan SP; Denson LA
Gastroenterology; 2017 May; 152(6):1345-1357.e7. PubMed ID: 28132889
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis.
Pang X; Song H; Li X; Xu F; Lei B; Wang F; Xu J; Qi L; Wang L; Tan G
J Transl Med; 2023 Jan; 21(1):30. PubMed ID: 36647141
[TBL] [Abstract][Full Text] [Related]
29. TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease Patients.
Ślebioda TJ; Bojarska-Junak A; Stanisławowski M; Cyman M; Wierzbicki PM; Roliński J; Celiński K; Kmieć Z
Scand J Immunol; 2015 Oct; 82(4):352-60. PubMed ID: 26072972
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil Extracellular Traps Sustain Inflammatory Signals in Ulcerative Colitis.
Dinallo V; Marafini I; Di Fusco D; Laudisi F; Franzè E; Di Grazia A; Figliuzzi MM; Caprioli F; Stolfi C; Monteleone I; Monteleone G
J Crohns Colitis; 2019 May; 13(6):772-784. PubMed ID: 30715224
[TBL] [Abstract][Full Text] [Related]
31. Kuijieling decoction regulates the Treg/Th17 cell balance in ulcerative colitis through the RA/RARα signaling pathway.
Xiao S; Yan Y; Shao M; Zhou X; Niu Z; Wu Y; Li Y; Cui Y; Long Y; Du Q
J Ethnopharmacol; 2024 Jan; 318(Pt A):116909. PubMed ID: 37451490
[TBL] [Abstract][Full Text] [Related]
32. Tissue levels of tumor necrosis factor-alpha correlates with grade of inflammation in untreated ulcerative colitis.
Olsen T; Goll R; Cui G; Husebekk A; Vonen B; Birketvedt GS; Florholmen J
Scand J Gastroenterol; 2007 Nov; 42(11):1312-20. PubMed ID: 17852866
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of interleukin 17 in inflammatory bowel disease.
Fujino S; Andoh A; Bamba S; Ogawa A; Hata K; Araki Y; Bamba T; Fujiyama Y
Gut; 2003 Jan; 52(1):65-70. PubMed ID: 12477762
[TBL] [Abstract][Full Text] [Related]
34. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis.
Tsukada Y; Nakamura T; Iimura M; Iizuka BE; Hayashi N
Am J Gastroenterol; 2002 Nov; 97(11):2820-8. PubMed ID: 12425554
[TBL] [Abstract][Full Text] [Related]
35. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.
Weidlich S; Bulau AM; Schwerd T; Althans J; Kappler R; Koletzko S; Mayr D; Bufler P
J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):e18-26. PubMed ID: 24732025
[TBL] [Abstract][Full Text] [Related]
36. Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis.
Iboshi Y; Nakamura K; Fukaura K; Iwasa T; Ogino H; Sumida Y; Ihara E; Akiho H; Harada N; Nakamuta M
J Gastroenterol; 2017 Mar; 52(3):315-326. PubMed ID: 27178567
[TBL] [Abstract][Full Text] [Related]
37. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
38. Suppression of pro-inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis.
Kankuri E; Hämäläinen M; Hukkanen M; Salmenperä P; Kivilaakso E; Vapaatalo H; Moilanen E
Scand J Gastroenterol; 2003 Feb; 38(2):186-92. PubMed ID: 12678336
[TBL] [Abstract][Full Text] [Related]
39. Immune response and inflammatory pathway of ulcerative colitis.
Tatiya-Aphiradee N; Chatuphonprasert W; Jarukamjorn K
J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):1-10. PubMed ID: 30063466
[TBL] [Abstract][Full Text] [Related]
40. Peripheral cytokine profile in Chilean patients with Crohn's disease and ulcerative colitis.
Beltrán CJ; Candia E; Erranz B; Figueroa C; Gonzalez MJ; Quera R; Hermoso MA
Eur Cytokine Netw; 2009 Mar; 20(1):33-8. PubMed ID: 19318319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]